Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABUS
RIGL
Add up to 3 more stocks
ABUS
Arbutus Biopharma Corp
-4.07%
$4.48-0.19Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$884.97M
52W Range
$3.50 - $5.45
RIGL
Rigel Pharmaceuticals, Inc.
-3.52%
$46.11-1.68Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$853.13M
52W Range
$24.95 - $52.24
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 5.74 | 2.83 |
| Forward P/E | 6.05 | 13.44 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.42 | 2.01 |
| P/S Ratio | 4.87 | 3.08 |
| P/FCF Ratio | N/A | 10.75 |
| EV/EBITDA | 5.90 | 9.28 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 91.4% |
| Operating Margin | -192.1% | 42.6% |
| Net Margin | 84.2% | 116.3% |
| ROE | 59.2% | 75.7% |
| ROA | 55.9% | 61.8% |
| ROIC | 54.4% | 18.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 81.42 | 1.95 |
| Quick Ratio | 81.42 | 1.79 |
| Debt/Equity | 0.01 | 0.09 |
| Interest Coverage | -278.88 | 17.14 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.